Tahoe Therapeutics and Alloy Therapeutics announced today that they are forming a jointly seeded new company focused on developing first-in-class antibody-drug conjugates (ADCs) for patients with hard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback